Affiliation:
1. Shahid Beheshti University of Medical Sciences,Traditional Medicine and Materia Medica Research Center and Department of Traditional Pharmacy,Tehran,Iran
Abstract
Alzheimer’s disease is known to be the most common cause of dementia
with increasing number of people suffering every year. In healthy adults, there are
millions of neurons in the brain. Degeneration starts and extends in Alzheimer's disease
many years before the initial symptoms show up. The neurons taking part in cognitive
functions destroy gradually leading to functional disability and finally to death. β amyloid plaques and tau protein are known as the most responsible causes of
Alzheimer’s disease resulting in neurodegeneration. Inflammation, atrophy and
dysfunction in glucose metabolism will follow. The three stages of the disease include
mild, moderate and severe. The patient will have difficulty in cognitive functions, show
changes in behavior and will need care for everyday needs, which increases by the
disease progress. There are pharmacologic and non-pharmacologic approaches for
treatment. The pharmacologic approaches comprise acetylcholinesterase (AChE)
inhibitors such as donepezil or N-methyl-d-aspartate (NMDA) receptor blockers like
memantine. None of them stops the disease but alleviate the symptoms. On the other
hand, non-pharmacologic approaches are usually used to improve the patient’s quality
of life or improve the behavioral aspects of the disease. Recently, involving physical
activity as a non-pharmacologic method of treatment for Alzheimer’s disease has been
the focus of many studies. This chapter will have a glance at the clinical trials that were
conducted regarding the effect of physical exercise and its impact on Alzheimer’s
disease.<br>
Publisher
BENTHAM SCIENCE PUBLISHERS